SRPT T-629-.8, T-6889.1, T-6316.4 DT15-A M S & b -lb itf 3M M E D IC A L DEPARTMENT, CORPORATE TOXICOLOGY Title: Inter-Species Comparison of Mechanisms Fluorochemical Toxicity following Intraperitoneal dosing of perfluorooctanesulfonate (PFOS, T-6295) or ammonium perfl^iorooctanoate (APFO, T-6889) in Rats and Guinea Pigs and oral dosing of N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316) in Rats.

P. z z6 -37773 ~~- PFOA : A 96-HOUR STATIC-RENEWAL ACUTE TOXICITY TEST WITH Chironomus tentans AMENDED FINAL REPOR T WILDLIFE INTERNATIONAL, LTD .

AR226-2803 TRADE SECRET Study Title H-24648 and H-24020: Biopersistence Screening 20-Dose Oral Gavage Study in Rats with Recovery Period Laboratory Project ID: DuPont-5207 AUTHOR: Susan A.

VOSS et al and DOES 1 to 300 Defendants ) Case BC 368967 ) Action Filed April 5 2007 ) Judge Hon James C Chalfant Dept. 13 ) ) DEFENDANT KUBOTA . ) CORPORATION'S RESPONSES TO ) PLAINTIFF'S FORM ) INTERROGATORIES ) . ) SET NOS 1-5 2) ) ) PROPOUNDING PARTY : RESPONDING PARTY : SET NOS : 7 Plaintiff CHRIS WEBBER Defendant KUBOTA CORPORATION 1-5 Defendant KUBOTA CORPORATION Defendant hereby responds to Plaintiff Chris Webber's Plaintiff Form Interrogatories Set Nos 1-5 as follows 27 /// 28 ff i DEFENDANT KUBOTA CORPORATION'S RESPONSES TO PLAINTIFF'S FORM INTERROGATORIES SET NOS 1-5 6078101 ne 6 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Ssepmne PRELIMINARY STATEMENT These responses are made solely for the purpose of and in relation to this action Each answer is given subject to all appropriate objections including but not limited to objections concerning competency relevancy materiality propriety and admissibility which would require the exclusion of any statement contained herein where made by a witness present and testifying in court All such objections and grounds therefore are reserved and may be interposed at the time of trial It should be noted that this responding party has not fully completed its investigation of the facts relating to this case has not yet fully completed its discovery in this matter and has not completed its preparation for trial All of the answers contained herein are based only upon such information and documents which are presently available to and specifically known to this responding party and disclose only those contentions which presently occur to such responding party It is anticipated that further discovery independent investigation legal research and analysis will supply additional facts add meaning to the known facts as well as establish entirely new factual conclusions and legal contentions all of which may lead to substantial additions to changes in and variations from the contentions herein set forth It should further be noted that Kubota Corporation ceased the sale of asbestos cement pipe in October 1975.

. 25 3M Environmental Laboratory OB Final Report- Analytical Study Single-dose Intravenous Pharmacokinetic Study of T-6049 in Rabbits In-Vivo Study Reference Number: HWI#6329-129 Study Number: AMDT-112294.1 Test Substance: FC-95 (T-6049) Name and Address of Sponsor: 3M SCD Division 367 Grove Street St.

3M GLP10-01-02; Interim Report 23 Analysis of PFBS, PFHS, and PFOS in Groundwater Samples Off-Site 610 Wells; September 2011 GLP10-01-02; Interim R eport 23 - A n a lysis o f PFBS.

SRPT T-6295.8, T-6889.1, T-6316.4 DTI 5-A A Z226-oQ - 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Title: Inter-Species Comparison of Mechanisms Fluorochemical Toxicity following Intraperitoneal dosing of perfluorooctanesulfonate (PFOS, T-6295) or ammonium perfluorooctanoate (APFO, T-6889) in Rats and Guinea Pigs and oral dosing of N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316) in Rats.

f* JOSJPK I.

Final Report on A Pharmacokinetic Study of Potassium Perfluorooctanoate in the Cynomolgus Monkey T " ~ 7^ r ^ - l To: 3M Corporation P.O.

q Final Report on A Pharmaeokinetic Study of Potassium Perfluorooetanoate in the Cynomolgus Monkey -r--7_-o7.1 \ To: 3M Corporation P.O.

SRPT T-6295.8, T-6889.1, T-6316.4 DTI 5-A 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Title; Inter-Species Comparison of Mechanisms Fluorochemicai Toxicity following Intraperitoneal dosing of perfluorooctanesulfonate (PFOS, T-6295) or ammonium perfluorooctanoate (APFO, T-6889) in Rats and Guinea Pigs and oral dosing of N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316) in Rats.

MAMACikMU.N I' CORPORATION VIA FEDERAL EXPRESS MARGARET [- BAUMGARDNER RESEARCH COORDINATOR August 5, 2009 Taylor Kerns Simmons, Browder, Gianaris, Angelides & Bamerd 707 Berkshire Boulevard East Alton, IL 62064 Re; Cellulo Dear Mr.

Leroy Gardner of Saranac Lake, a leading researcher in the field of dust-related diseases, to survey conditions and examine workers in the plant.

DuPont objects to the Discovery Requests, pursuant to Rule 26(b)(1) of the West Virginia Rules of Civil Procedure, to the extent that they seek to elicit information that is not relevant to the subject matter involved in the pending action and is not reasonably calculated to lead to the discovery ofadmissible evidence. 2.

Page 1 of 28 ---------BEGIN PRIVACY-ENHANCED MESSAGE---------Proc-Type: 2001,MIC-CLEAR Originator-Name: webmasterGwww.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7zlT+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VN4gRaeNaxoN2TRiZUlGA9JLsbSZBLKHZaZfx0hxwgI3rcCenusM4h/NF3199KQh aqkgsz27aTQCWoua76GMJQ== <SEC-DOCUMENT>0000025890-99-000028.txt : 19991108 <SEC-HEADER>0000025890-99-000028.hdr.sgml : 19991108 ACCESSION NUMBER: 0000025890-99-000028 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 19990930 FILED AS OF DATE: 19991105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROWN CORK & SEAL CO INC CENTRAL INDEX KEY: 0000025890 STANDARD INDUSTRIAL CLASSIFICATION: METAL CANS [3411] IRS NUMBER: 231526444 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SEC ACT: SEC FILE NUMBER: FILM NUMBER: 10-Q 001-02227 99742358 BUSINESS ADDRESS: STREET 1: CITY: STATE: ZIP: BUSINESS PHONE: </SEC-HEADER> <DOCUMENT> <TYPE>10-Q <SEQUENCE>1 <DESCRIPTION>THIRD QUARTER 1999 FORM 10-Q <TEXT> ONE CROWN WAY PHILADELPHIA PA 19154 2156985100 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 1999 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 1-2227 http://www.sec.gov/Archives/edgar/data/25890/0000025890-99-000028.txt 12/08/1999 Page 2 of 28 CROWN CORK 4 SEAL COMPANY, INC.